Acta Otolaryngol:扁桃体和外周血中磷酸胆碱特异性免疫响应对lgA肾病作用分析

2019-02-10 AlexYang MedSci原创

扁桃体切除术组合类固醇脉冲疗法被报道对lgA肾病患者是有效的。然而,扁桃体切除术对lgA的作用机制仍旧未知。最近,有研究人员调查了lgA肾病患者中扁桃体和外周血磷酸胆碱(PC)特异性免疫响应的参与情况。研究人员分离了扁桃体淋巴细胞并且测量了PC特异性免疫球蛋白产生细胞的数目。另外,研究人员对血清PC特异性免疫球蛋白水平进行了定量并与实验室数据进行了比较。研究人员发现,PC特异性lgA产生细胞数目在

扁桃体切除术组合类固醇脉冲疗法被报道对lgA肾病患者是有效的。然而,扁桃体切除术对lgA的作用机制仍旧未知。最近,有研究人员调查了lgA肾病患者中扁桃体和外周血磷酸胆碱(PC)特异性免疫响应的参与情况。

研究人员分离了扁桃体淋巴细胞并且测量了PC特异性免疫球蛋白产生细胞的数目。另外,研究人员对血清PC特异性免疫球蛋白水平进行了定量并与实验室数据进行了比较。研究人员发现,PC特异性lgA产生细胞数目在lgA肾病患者的扁桃体中增加。在起始透析更高风险组中,细胞数值显著增加。与之相反,起始透析更低风险组中,PC特异性lgM水平在血清中显著提高。

最后,研究人员指出,在扁桃体和外周血中的PC特异性免疫响应可能与lgA肾病的病理机制和恶化有关。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1899279, encodeId=d80318992e9b1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Jul 20 06:54:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849635, encodeId=abd318496358c, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Dec 22 16:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527408, encodeId=c8e7152e40878, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578549, encodeId=765e15e8549ec, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944052, encodeId=90741944052f4, content=<a href='/topic/show?id=f48228993d0' target=_blank style='color:#2F92EE;'>#免疫响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28993, encryptionId=f48228993d0, topicName=免疫响应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Jan 07 21:54:00 CST 2020, time=2020-01-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1899279, encodeId=d80318992e9b1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Jul 20 06:54:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849635, encodeId=abd318496358c, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Dec 22 16:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527408, encodeId=c8e7152e40878, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578549, encodeId=765e15e8549ec, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944052, encodeId=90741944052f4, content=<a href='/topic/show?id=f48228993d0' target=_blank style='color:#2F92EE;'>#免疫响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28993, encryptionId=f48228993d0, topicName=免疫响应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Jan 07 21:54:00 CST 2020, time=2020-01-07, status=1, ipAttribution=)]
    2019-12-22 windight
  3. [GetPortalCommentsPageByObjectIdResponse(id=1899279, encodeId=d80318992e9b1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Jul 20 06:54:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849635, encodeId=abd318496358c, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Dec 22 16:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527408, encodeId=c8e7152e40878, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578549, encodeId=765e15e8549ec, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944052, encodeId=90741944052f4, content=<a href='/topic/show?id=f48228993d0' target=_blank style='color:#2F92EE;'>#免疫响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28993, encryptionId=f48228993d0, topicName=免疫响应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Jan 07 21:54:00 CST 2020, time=2020-01-07, status=1, ipAttribution=)]
    2019-02-12 grace5704
  4. [GetPortalCommentsPageByObjectIdResponse(id=1899279, encodeId=d80318992e9b1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Jul 20 06:54:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849635, encodeId=abd318496358c, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Dec 22 16:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527408, encodeId=c8e7152e40878, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578549, encodeId=765e15e8549ec, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944052, encodeId=90741944052f4, content=<a href='/topic/show?id=f48228993d0' target=_blank style='color:#2F92EE;'>#免疫响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28993, encryptionId=f48228993d0, topicName=免疫响应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Jan 07 21:54:00 CST 2020, time=2020-01-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1899279, encodeId=d80318992e9b1, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Jul 20 06:54:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849635, encodeId=abd318496358c, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Dec 22 16:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527408, encodeId=c8e7152e40878, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578549, encodeId=765e15e8549ec, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Tue Feb 12 07:54:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944052, encodeId=90741944052f4, content=<a href='/topic/show?id=f48228993d0' target=_blank style='color:#2F92EE;'>#免疫响应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28993, encryptionId=f48228993d0, topicName=免疫响应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Jan 07 21:54:00 CST 2020, time=2020-01-07, status=1, ipAttribution=)]

相关资讯

Cancer:腭扁桃体鳞状细胞癌单边和双边调强放射治疗比较

最近,有作者提出了这样的一个假设,即对患有单侧性的腭扁桃体癌和N0到N2b疾病分级且具有相似肿瘤结果的病人来说,单边调强放射治疗(IMRT)与双边IMRT相比会减少毒性。研究有154名病人在1997年到2013年接受了术后IMRT治疗。研究人眼前瞻性的收集了2005年到2013年的数据,并且回顾性的收集了2005年前的数据。对那些患有单侧性初级和N0到N2b颈部分级的病人,48名病人接受了单边IM

警惕:难缠的咽痛——扁桃体周围脓肿

临床工作中,遇到难缠逐渐加重的咽痛,切勿以为都是急性扁桃体炎,应警惕扁桃体周围脓肿的形成,早期发现,早期抽脓!

扁桃体淋巴瘤1例

患者男,82岁。

Auris Nasus Larynx:成年人扁桃腺切除术分析

扁桃腺切除术是外科手术中耳鼻喉科专家最为常用的手术之一,并且尽管是一个相对简单的手术,它能够产生相当大比例的并发症,比如术后出血。最近,有研究人员描述了该外科手术的适应症和最常见的并发症,分析了是否扁桃体支柱的外科手术缝合线对出血具有影响以及研究了住院数据和并发症控制的重要性。研究为回顾性的研究,包括了326名经历了扁桃腺切除的病人,时间为2006年到2014年,地点为研究人员所在的耳鼻喉部门。研

Aust J Gen Pract:增殖腺扁桃体切除术后,伴随残余打鼾和睡眠症状儿童过敏性鼻炎发生率研究

在儿童中,过敏性鼻炎对睡眠障碍呼吸(SDB)具有贡献性作用。尽管增殖腺扁桃体切除术经常用来治疗SDB,一些患者仍旧会伴随残余的睡眠症状并回诊。最近,有研究人员在经历增殖腺扁桃体切除术的儿童中通过放射变应性吸附法测试(RAST)对过敏性鼻炎的发生率进行评估,这些儿童均具有残余的打鼾或者睡眠障碍现象。研究是一个回顾性的研究,包括了500名增殖腺扁桃体切除术术后的儿童。研究人员评估和记录了残余的打鼾、睡

Br J Gen Pract:许多儿童切除扁桃体并无必要

英国伯明翰大学日前发布一项公报说,针对英国儿童的研究显示,每8名切除扁桃体的儿童中,就有7名儿童可能并不会因此受益。